Stallion India Fluorochemicals Ltd issues revised Q2 FY27 release, reporting 31.79% year-on-year revenue growth to ₹13,937.33 lakh
- Revision supersedes the 15 November release; unaudited results for the quarter and half year ended 30 September 2026 are unchanged.
- Q2 operating EBITDA before ESOP rose 0.43% to ₹1,583.54 lakh (about 11.4% margin); operating PAT before ESOP increased 4.78% to ₹1,196.21 lakh.
- Khalapur high-purity helium facility is operational; the release also outlined Mambattu expansion and R-32 projects.
- H1 FY27 ESOP expense was ₹950.92 lakh and excluded from the highlighted adjusted metrics.
